Develops a one-time minimally invasive cryoablation device treating obesity as an alternative to bariatric surgery and GLP-1 drugs.
Create a free EquityFlow account to see Sedivention's 2 funding rounds, 6 investors, 12 similar companies.
Sign up free → Sign in